GSK Consumer Healthcare has recalled approximately 433,600 bottles of five different Excedrin pain relief products because the plastic bottles may have a hole in the bottom. These products contain aspirin and acetaminophen, and a hole in the bottle allows children to access the medication, bypassing the child-resistant closure and posing a risk of poisoning. The recall includes various sizes of Excedrin Migraine, Extra Strength, PM Headache, and Tension Headache sold nationwide between March 2018 and September 2020. No injuries have been reported, and consumers with affected bottles can contact GSK for a full refund.
A manufacturing defect can cause a hole to form in the bottom of the medicine bottle, allowing children to potentially access and swallow the medication. This poses a significant poisoning risk as the products contain aspirin and acetaminophen, which are hazardous if ingested by children in unregulated amounts.
Consumers should immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the bottle to determine if there is a hole. If there is a hole in the bottle, contact GSK Consumer Relations for information on how to receive a prepaid shipping label for return to receive a full refund. Bottles without a hole can be retained and used as directed.
Recalled Excedrin with hole in the bottom of the bottle
Recalled Excedrin Migraine Caplets (50, 80, 100, 125, 200, 250 and 300-count)
Recalled Excedrin Migraine Geltabs (50, 80, 100, 125, 200, 250 and 300-count)
Recalled Excedrin Extra Strength Caplets (50, 80, 100, 125, 200, 250 and 300-count)
Recalled Excedrin PM Headache Caplets (50, 80, 100, 125, 200, 250 and 300-count)
Recalled Excedrin Tension Headache Caplets (50, 80, 100, 125, 200, 250 and 300-count)
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: CPSC Notice · Raw API Response